All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2004-002380-24 | An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung ma... | 2008-03-31 | due-trials |
Completed, but no date, and reported results Terminated | 2004-005028-42 | A prospective, multi-centre, phase III-b study of TachoSil in paediatric patients scheduled for resection of the liver with or without segmental liver transplantation | bad-data | |
Reported results | 2005-000730-20 | An open label, international, multi centre, parallel group, phase III b, randomised trial, investigating lumbar spine Bone Mineral Density (BMD) changes in postmenopausal women with primary osteoporos... | 2011-01-14 | due-trials |
Reported results | 2005-002347-82 | Intranasal fentanyl for the treatment of breakthrough pain in cancer patients: A randomised, double-blind, placebo-controlled, cross-over confirmatory trial testing the doses 50, 100 and 200 µg fentan... | 2007-05-13 | due-trials |
Reported results | 2005-002348-24 | A double-blind, randomised, placebo-controlled trial confirming the efficacy of intranasal fentanyl titrated to 50, 100 or 200 µg with an open long-term safety follow-up in cancer patients with breakt... | 2008-08-29 | due-trials |
Reported results | 2005-003485-42 | Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks | 2007-08-14 | due-trials |
Reported results | 2005-003937-42 | Effect of roflumilast on exacerbation rate in patients with COPD A 52 weeks, double-blind study with 500 mcg roflumilast once daily versus placebo | 2008-09-25 | due-trials |
Reported results | 2005-003938-18 | Effect of roflumilast on exacerbation rate in patients with COPD. A 52 weeks, double-blind study with 500 mcg roflumilast once daily versus placebo | 2008-08-14 | due-trials |
Reported results | 2005-005080-28 | Effect of roflumilast in COPD patients treated with salmeterol. A 24 week, double blind study with 500 mcg roflumilast once daily versus placebo | 2008-02-12 | due-trials |
Reported results | 2005-005702-23 | Efficacy of 500µg roflumilast once daily versus placebo over 12 weeks in patients with diabetes mellitus type 2. A double blind, parallel group, phase IIb, proof of concept clinical study | 2008-01-29 | due-trials |
Reported results | 2006-000028-15 | A randomised, open label, parallel-group, multi-centre trial to compare the efficacy and safety of TachoSil versus standard haemostatic treatment in cardiovascular surgery | 2007-12-17 | due-trials |
Reported results | 2006-000803-40 | A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW) | 2007-11-29 | due-trials |
Reported results | 2006-000927-33 | Confirmation of superiority of complete remission concept vs classical healing concept for treatment of patients with erosive GERD | 2007-10-11 | due-trials |
Reported results | 2006-002087-26 | An open label, comparative, randomised, balanced crossover trial comparing nasal fentanyl and oral transmucosal fentanyl (Actiq) in breakthrough pain in patients with cancer | 2008-09-05 | due-trials |
Completed, but no date, and reported results Terminated | 2006-004007-19 | A multi-centre, double-blind, placebo-controlled, randomised, parallel group clinical trial to evaluate efficacy and safety of Actovegin® in diabetic type 2 patients with symptomatic diabetic peripher... | bad-data | |
Reported results | 2006-004508-37 | Effect of roflumilast in COPD patients treated with tiotropium. A 24-week, double-blind study with 500 g roflumilast once daily versus placebo. | 2008-07-07 | due-trials |
Ongoing | 2006-005570-42 | "Ensayo clínico multicéntrico, longitudinal, prospectivo, fase IV que compara dos técnicas de imagen (ImaTx y DXA) para evaluar el efecto anabólico de la PTH (1-84) en mujeres postmenopáusicas con... | not-yet-due | |
Not reported | 2006-006064-32 | A 24-week, international, multi centre, randomised, double-blind, double-dummy, parallel group, phase IV clinical trial investigating changes in back pain in postmenopausal women with an osteoporosis ... | 2010-05-06 | due-trials |
Reported results | 2006-006065-16 | A 24-week, international, multi centre, randomised, open label, parallel group, phase IV clinical trial investigating changes in bone formation markers in postmenopausal women with primary osteoporosi... | 2009-01-26 | due-trials |
Reported results | 2007-003736-34 | Effect of low dose continuous treatment with Ciclesonide over one year on the time to first exacerbation in children with mild asthma versus intermittent treatment for exacerbations | 2009-06-25 | due-trials |
Reported results | 2007-006121-26 | An international, randomised, double blinded, multi-centre, active- and placebo-controlled dose response trial to evaluate the efficacy and safety of SABER-Bupivacaine for postoperative pain control i... | 2010-06-01 | due-trials |
Reported results | 2007-006122-96 | An international, randomised, double blinded, multi-centre, active- and placebo-controlled dose response trial to evaluate the efficacy and safety of SABER-Bupivacaine for postoperative pain control i... | 2011-02-04 | due-trials |
Reported results | 2007-007254-62 | Non-randomised, open, multi-center trial evaluating feasibility and safety of TachoSil application on a colorectal anastomosis. | 2009-07-16 | due-trials |
Reported results | 2009-013056-71 | Ensayo abierto, aleatorizado, multicentrico, controlado con grupo paralelo para evaluar la eficacia y seguridad de TachoSilâ frente a la práctica habitual en técnicas de sellado de duramadre para la... | 2013-09-06 | due-trials |
Reported results | 2009-015589-74 | A controlled, randomized, double-blind, cross-over study of the onset of analgesic effect of two formulations of ibuprofen for the treatment of pain after oral surgery. | 2010-03-29 | due-trials |
Reported results | 2010-019685-87 | Effect of roflumilast on exacerbation rate in patients with COPD treated with fixed combinations of LABA and ICS. A 52-week, randomised double-blind trial with roflumilast 500 ?g versus placebo Efe... | 2014-07-31 | due-trials |
Reported results | 2010-021096-85 | A dose titrated clinical trial with a placebo-controlled, double-blind, randomised, cross-over phase to demonstrate the efficacy of 400 μg Intranasal fentanyl (INFS) dose strength, and to evaluate 12 ... | 2013-01-02 | due-trials |
Reported results Terminated | 2010-022378-15 | VELVET (Veltuzumab various doses exploratory trial), a randomized, double blind, placebo controlled, multicentre, multinational phase II dose range finding trial in subjects with moderate to severe rh... | 2012-10-01 | due-trials |
Not reported Terminated | 2011-002101-29 | A randomised, double-blind, 4-weeks cross-over trial to investigate the effect of 500 µg roflumilast tablets once-daily versus placebo on pulmonary function, asthma symptoms and inflammatory markers i... | 2012-01-26 | due-trials |
Reported results Terminated | 2011-002905-31 | Effect of roflumilast 500 μg tablets once daily at acute COPD exacerbations treated with standard therapy of oral steroids and antibiotics. A randomised, double-blind, placebo-controlled, parallel-gro... | 2014-04-14 | due-trials |